Urte Gayko

Urte Gayko currently works at Summit Therapeutics Ltd., as Director & Head-Regulatory Affairs and Summit Therapeutics, Inc., as Chief Regulatory & Pharmacovigilance Officer from 2023.
Dr. Gayko also formerly worked at Amgen, Inc., as Director-Regulatory Affairs from 1999 to 2008, Nektar Therapeutics, as Senior VP-Drug Development & Regulatory Affairs, Pharmacyclics LLC, as Vice President-Global Regulatory Affairs in 2012, and Nodality, Inc., as Vice President-Regulatory & Clinical Affairs from 2008 to 2012.
Dr. Gayko received her doctorate degree from Harvard University and undergraduate degree and graduate degree from Freie Universität Berlin.